Combination of circular dichroism spectroscopy and size-exclusion chromatography coupled with HDX-MS for studying global conformational structures of peptides in solution.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 06 08 2018
revised: 19 09 2018
accepted: 20 09 2018
entrez: 6 1 2019
pubmed: 6 1 2019
medline: 5 3 2019
Statut: ppublish

Résumé

Misfolding of therapeutic peptides and proteins can lead to numerous issues, ranging in severity, including loss of function, aggregation, immunogenicity, and cytotoxicity. A primary component of protein folding is secondary structure, including α-helices and β-sheets. Many native peptides and proteins are predominately α-helical therefore, it is of critical importance to develop robust and reliable analytical tools to investigate protein higher order structure, including the percentage of α-helix under various conditions, to evaluate protein folding and prevent the negative effects of misfolding. However, given the complexity of protein folding and higher order structure, it is unlikely that one technique will provide a comprehensive analysis. To bridge this gap, this study presents the combination of two orthogonal techniques - circular dichroism (CD) and size-exclusion chromatography-hydrogen-deuterium exchange-mass spectrometry (SEC-HDX-MS) to investigate global peptide and protein conformations. Also, the incorporation of trifluoroethanol (TFE), a known stabilizer of α-helical structures, into the analyses, aims to enhance the discrimination power of these two techniques by increasing the alpha helical stability range of study. CD data was used to estimate the percent of α-helix content and its thermal stability while online SEC-HDX-MS screening compared global conformational changes of each peptide based on a difference in the number of deuterons exchanged to protons, ΔHDX. The workflow described in this report can be very beneficial in pharmaceutical development. The model peptides were chosen to demonstrate the workflow with commercially available compounds. The goal of this study was to show a proof-of-concept for direct correlation of these methodologies and to estimate the percentage of α-helix content at a particular ΔHDX, which is indicative of the state of protein folding.

Identifiants

pubmed: 30609519
pii: S0039-9140(18)30994-9
doi: 10.1016/j.talanta.2018.09.077
pii:
doi:

Substances chimiques

Peptides 0
Solutions 0
Trifluoroethanol 75-89-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-182

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Nicole M Schiavone (NM)

Merck & Co., Inc., MRL, Analytical Research & Development, Rahway, NJ 07065, USA. Electronic address: nicole.schiavone@merck.com.

Gregory F Pirrone (GF)

Merck & Co., Inc., MRL, Analytical Research & Development, Rahway, NJ 07065, USA.

Erik D Guetschow (ED)

Merck & Co., Inc., MRL, Analytical Research & Development, Rahway, NJ 07065, USA.

Ian Mangion (I)

Merck & Co., Inc., MRL, Analytical Research & Development, Rahway, NJ 07065, USA.

Alexey A Makarov (AA)

Merck & Co., Inc., MRL, Analytical Research & Development, Rahway, NJ 07065, USA. Electronic address: alexey.makarov@merck.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH